Household transmission and disease transmissibility of a large HAV outbreak in Lazio, Italy, 2016-2017.


Journal

Epidemics
ISSN: 1878-0067
Titre abrégé: Epidemics
Pays: Netherlands
ID NLM: 101484711

Informations de publication

Date de publication:
12 2019
Historique:
received: 22 10 2018
revised: 13 05 2019
accepted: 05 06 2019
pubmed: 22 7 2019
medline: 25 7 2020
entrez: 22 7 2019
Statut: ppublish

Résumé

A major outbreak of Hepatitis A Virus (HAV) has swept through Europe between mid-2016 and 2017, mainly within the community of men who have sex with men (MSM). Over the same period, about 1000 outbreak-related cases of acute Hepatitis A (AHA) were recorded in Lazio region, Italy. We calibrated a Bayesian model to reconstruct likely transmission events within all 44 households where multiple infections were recorded, representing a total of 103 cases from the HAV outbreak in Lazio. Based on information on the observed times of symptom onset, we estimated the probability distribution function of the HAV generation time and used it to compute the effective and instantaneous reproduction numbers for the considered outbreak from the overall epidemic curve (N = 998 cases). We estimated a mean generation time of 30.2 days (95%CI: 25.2-33.0) and an effective reproduction number of about 1.63 (95% CI: 1.35-1.94). Transmissibility peaked in January 2017, shortly before targeted awareness and vaccination campaigns were put in place by health authorities; however, transmission remained above the epidemic threshold until June 2017. Within households, children (0-15) and young adults (16-30) infected preferentially individuals of the same age class, whereas transmission within older age groups was substantially homogeneous. These results suggest that the implemented interventions were able to slow down HAV transmission, but not to bring it rapidly to a halt. According to our estimates of the HAV transmissibility, about 50% of the at-risk persons should be immunized to prevent similar outbreaks in the future. Our results also indicate spillover from community transmission to household members, suggesting the opportunity of vaccinating household contacts of cases to prevent further spread of the epidemics.

Identifiants

pubmed: 31326355
pii: S1755-4365(18)30158-0
doi: 10.1016/j.epidem.2019.100351
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100351

Informations de copyright

Copyright © 2019 The Author. Published by Elsevier B.V. All rights reserved.

Auteurs

Giorgio Guzzetta (G)

Fondazione Bruno Kessler, via Sommarive 18, Povo (Trento) 38123, Italy. Electronic address: guzzetta@fbk.eu.

Claudia Minosse (C)

National Institute for Infectious Diseases Lazzaro Spallanzani - IRCSS, via Portuense 292, Rome 00149, Italy.

Raffaella Pisapia (R)

National Institute for Infectious Diseases Lazzaro Spallanzani - IRCSS, via Portuense 292, Rome 00149, Italy.

Emanuela Giombini (E)

National Institute for Infectious Diseases Lazzaro Spallanzani - IRCSS, via Portuense 292, Rome 00149, Italy.

Alessia Mammone (A)

National Institute for Infectious Diseases Lazzaro Spallanzani - IRCSS, via Portuense 292, Rome 00149, Italy.

Francesco Vairo (F)

National Institute for Infectious Diseases Lazzaro Spallanzani - IRCSS, via Portuense 292, Rome 00149, Italy.

Anna Rosa Garbuglia (AR)

National Institute for Infectious Diseases Lazzaro Spallanzani - IRCSS, via Portuense 292, Rome 00149, Italy.

Paola Scognamiglio (P)

National Institute for Infectious Diseases Lazzaro Spallanzani - IRCSS, via Portuense 292, Rome 00149, Italy.

Maria Rosaria Capobianchi (MR)

National Institute for Infectious Diseases Lazzaro Spallanzani - IRCSS, via Portuense 292, Rome 00149, Italy.

Stefano Merler (S)

Fondazione Bruno Kessler, via Sommarive 18, Povo (Trento) 38123, Italy.

Giuseppe Ippolito (G)

National Institute for Infectious Diseases Lazzaro Spallanzani - IRCSS, via Portuense 292, Rome 00149, Italy.

Simone Lanini (S)

National Institute for Infectious Diseases Lazzaro Spallanzani - IRCSS, via Portuense 292, Rome 00149, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH